Quick answers
- What is RYANODEX dantrolene sodium?
- RYANODEX dantrolene sodium is a brand name of Dantrolene sodium, a prescription medicine. The FDA NDC Directory lists 1 RYANODEX dantrolene sodium product in 1 strength and form.
- Who makes RYANODEX dantrolene sodium?
- Eagle Pharms holds the FDA application for RYANODEX dantrolene sodium (NDA205579, approved July 22, 2014).
- Is there a generic or store brand of RYANODEX dantrolene sodium?
- Other products of Dantrolene sodium are listed with the FDA, but none in exactly the same strength and form as a RYANODEX dantrolene sodium product.
- Has RYANODEX dantrolene sodium been recalled?
- No recall linked to RYANODEX dantrolene sodium products (by their NDC code or label) appears in the FDA enforcement reports we use.
What RYANODEX dantrolene sodium is
Each RYANODEX dantrolene sodium product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Dantrolene sodium · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| dantrolene sodium 250 mg/5 mL injection, suspension (intravenous) | RYANODEX dantrolene sodium | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Dantrolene sodium →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA205579 | Eagle Pharms | July 22, 2014 | 1 |
Companies that list RYANODEX dantrolene sodium
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of RYANODEX dantrolene sodium products.
- Eagle Pharmaceuticals, Inc.1 product
Recalls
No recall linked to RYANODEX dantrolene sodium products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.